Wed, Oct 22, 2014, 1:31 AM EDT - U.S. Markets open in 7 hrs 59 mins

Recent

% | $
Quotes you view appear here for quick access.

Impax Laboratories Inc. Message Board

  • For the third quarter 2013, analysts estimate IPXL will generate revenues of $111.8M, a decrease of 23.19% over the prior year third quarter results.
    IPXL reported today that the total revenues were $132.6 million for the third quarter 2013, compared to $145.6 million in the prior year period.
    IPXL also reported that the third quarter 2013 adjusted net income of $16.6 million, or $0.25 per diluted share, compared to adjusted net income of $33.0 million, or $0.48 per diluted share in the prior year period.
    Adjusted earnings before interest, taxes, depreciation and amortization was $34.2 million in the third quarter 2013, compared to $57.3 million in the prior year period.
    Cash and short-term investments increased $137.7 million to $436.6 million as of September 30, 2013, compared to $298.9 million as of December 31, 2012.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IPXL
27.01-0.41(-1.50%)Oct 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.